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 Reversible photocontrol of deoxyribozyme-catalyzed RNA cleavage under multiple 
turnover conditions 
 
Sonja Keiper and Joseph S. Vyle* 
 
Department of Chemistry and Chemical Engineering, David Keir Building, Stranmillis Road,  
Belfast BT9 5AG, UK 
 
Synthesis of phosphoramidites 
 
Dichloromethane (DCM) was dried under reflux over calcium hydride, distilled and stored over activated 3Å 
molecular sieves under argon. Triethylamine and n-butylamine were dried under reflux over calcium hydride and 
distilled immediately prior to use; N,N-diisopropylethylamine (DIPEA) was similarly purified but stored over 
activated 3Å molecular sieves for upto 6 weeks. DMF was obtained as anhydrous solvent over molecular sieves 
from Fluka. Dry MeOH was obtained by distillation from magnesium turnings and stored over activated 3Å 
molecular sieves. Tetrahydrofuran (THF) was distilled from sodium/benzophenone, stored over activated 3Å 
molecular sieves and used within 7 days. Acid-free ethyl acetate was prepared by prewashing with saturated 
Na2CO3. CDCl3 was passed through activated basic Al2O3 immediately prior to use and NMR’s obtained within 1 
hour (31P, 13C) or 12 hours (1H) of the CDCl3 solution being prepared. All other reagents were purchased from 
commercial suppliers and used without further purification. Silica gel (particle size 30–60 µm) for flash column 
chromatography was obtained from BDH and dried at 300°C immediately prior to use. 
UV-Visible data were obtained with a VARIAN CARY 100 Spectrometer. Nuclear Magnetic Resonance (NMR) 
spectra were run on Bruker AC-250 and AMX-400 spectrometers.  
 
o-Phenylazobenzoic acid-N-hydroxysuccinimidyl ester.  
To a stirred suspension of o-phenylazobenzoic acid (452 mg, 2.0 mmol) and N-
hydroxysuccinimide (255 mg, 2.2 mmol) in anhydrous DCM (10 ml) N,N’-
dicyclohexylcarbodiimide (454 mg, 2.2 mmol) was added at room temperature 
under argon. After 45 min, precipitated N,N’-dicyclohexylurea was removed by 
filtration and solvent removed in vacuo. The residual brown solid was purified by 
silica gel column chromatography eluting with anhydrous DCM to yield the 
product as a moisture-sensitive brown-orange solid (565 mg, 87%). 1H NMR (300 MHz, CDCl3, 20°C, TMS) d = 
2.92 (4H, s, 2 x CH2), 7.50 – 7.60 (4H, m, H3, H4, H5, PhN2; H4 ArCO), 7.74 (2H, m, H2, H6 PhN2), 8.06 (3H, 
m, H3, H5, H6 ArCO); 13C (76 MHz, CDCl3, 20°C, TMS) d = 26.2, 119.0, 124.2, 124.40, 129.6, 130.5, 131.3, 
132.3, 134.3, 152.7, 152.9, 153.0, 169.4; ES+ MS m/z = 324 (M+H), 346 (M+Na) 
 
5’-O-(4,4’-dimethoxytrityl)-2’-(N-(o-phenylazo)benzamido)-2’-deoxyuridine.  
To a stirred solution of o-phenylazobenzoic acid-N-hydroxysuccinimidyl ester 
(260 mg, 0.80 mmol) in anhydrous DMF (5 ml) at room temperature was added 
n-butylamine (10 µl, 0.10 mmol) and the reaction mixture maintained under 
these conditions for a further 10 min. This solution was transferred under argon 
to a flask containing 5’-O-(4,4’-dimethoxytrityl)-2’-amino-2’-deoxyuridine (250 
mg, 0.46 mmol) and N,N-diisopropylethylamine (DIPEA: 80 µl, 0.47 mmol) 
added. The reaction was stirred under ambient conditions for a further 6 hours, a 
further aliquot of DIPEA (100 µl, 0.59 mmol) was added and the reaction stored 
at 3°C overnight. Excess activated ester was quenched by addition of n-butylamine (190 µl, 1.92 mmol) and 
stirring at room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate (250 ml) and washed 
successively with aqueous saturated NaHCO3 (2 x 150 ml) and saturated NaCl (2 x 150 ml). The organics were 
dried over anhydrous sodium sulfate, filtered and solvent removed in vacuo. The resultant red gum was purified 
by silica gel column chromatography, eluting with a gradient of 0 – 2% (v/v) methanol in DCM containing 1% 
(v/v) triethylamine to give the title compound as an orange solid (250 mg, 72 %). 1H NMR (300 MHz, CDCl3, 
20°C, TMS) d = 3.42 (2H, yd, H5’, H5’’), 3.79 (6H, s, 2x CH3O), 4.17 (1H, m, H4’), 4.52 (1H, dd, 3J (H,H) = 
1.8, 5.7 Hz, H3’), 5.03 (1H, m, H2’), 5.45 (1H, d 3J (H,H) = 8.1 Hz, H5), 6.18 (1H, d 3J (H,H) = 7.8 Hz, H1’), 
6.85 (4H, d 3J (H,H) = 8.4 Hz, DMTrH o to OMe), 7.29 – 7.60 (14H, m, DMTr-H, AB-H), 7.70 (1H, d 3J (H,H) 
= 8.1 Hz, H6), 7.77 (1H, m, AB-H), 7.96 (2H, m, AB-H), 8.31 (1H, m, AB-H), 9.17 (1H, d 3J (H,H) = 7.8 Hz, 
AB-H);13C NMR (126 MHz, CDCl3, 20°C, TMS) d = 54.3, 55.6, 62.8, 70.2, 84.5, 86.0, 86.2, 101.7, 112.3, 
115.2, 122.1, 122.7, 126.1, 127.0, 127.2, 128.4, 128.4, 129.2, 129.6, 130.3, 130.4, 131.0, 131.2, 134.3, 134.5, 
139.5, 143.3, 148.8, 149.8, 151.3, 157.7, 162.2, 165.6; HRMS (ESI) 753.2789 (calc.753.2799 for MH+). 
 
 5’-O-(4,4’-dimethoxytrityl)-2’-(N-(o-phenylazo)benzamido)-2’-deoxyuridine-3’-O-(2-cyanoethyl-N,N-
diisopropyl-amino)-phosphoramidite.  
To a stirred solution of 5’-O-(4,4’-dimethoxytrityl)-2’-(N-(o-
phenylazo)benzamido)-2’-deoxyuridine (180 mg, 0.24 mmol) and DIPEA (90 µl, 
0.98 mmol) in anhydrous DCM (4 ml) and THF (1 ml) at room temperature was 
added 2-cyanoethyl-N,N-diisopropylaminochlorophosphoramidite (86 µl, 0.53 
mmol) dropwise over 3 min. The reaction was maintained under these conditions 
for a further 30 min and then quenched following addition of anhydrous 
methanol (60 µl, 1.48 mmol) and DIPEA (60 µl, 0.65 mmol) and stirring for a 
further 10 min. The reaction mixture was diluted with acid-free ethyl acetate (50 
ml) and washed successively with aqueous saturated NaHCO3 (2 x 50 ml), 
saturated NaCl (1 x 50 ml). The organics were dried over anhydrous sodium sulfate, filtered and solvent removed 
in vacuo. The resultant solid was purified by silica gel column chromatography, eluting with 2% (v/v) solutions 
of triethylamine in 3:1 DCM:40-60 petroleum ether; pure DCM and 3:1 DCM : ethyl acetate. The title compound 
was isolated as a brown foam (194 mg, 0.20 mmol, 85 %). 1H NMR (300 MHz, CDCl3, 20°C, TMS) d = 0.80 – 
1.10 (¶12H, m 2 x (CH3)2), 1.93 and 2.17 (2H, 2xm, CH2CN), 3.21 – 3.59 (¶6H, m, H5’, H5’’, (-CH)2N, CH2O), 
3.81 (6H, 2xs, 2xCH3O), 4.25 and 4.37 (1H, 2xs, H4’), 4.55 and 4.73 (1H, 2xdd, 5.0, 11.4, 5.3, 10.6,  H2’), 5.23 
and 5.32 (1H, 2xm, H3’), 5.43 (1H, d 3J (H,H) = 8.2 Hz, H5), 6.34 (1H, yt, 3J (H,H) = 8.2 Hz, H1’), 6.88 (4H, d 
3J (H,H) = 8.9 Hz, DMTrH o- to OMe), 7.30 – 7.70 (¶12H, m, DMTrH, NHC(O)AB AB-H) 7.73 and 7.79 (1H, 
2xd 3J (H,H) = 9.3, 9.3 Hz, H6), 7.87 (1H, m, AB-H) 8.00 (2H, m, AB-H) 8.36 and 8.40 (1H, 2xm, AB-H), 8.85 
and 9.06 (1H, 2xd, 3J (H,H) = 8.2 Hz AB-H); 31P NMR (121 MHz, CDCl3, 20°C, 85% H3PO4) d = 149.6, 147.9 
 
m-Phenylazobenzoic acid-N-hydroxysuccinimidyl ester.  
To a stirred suspension of m-phenylazobenzoic acid (452 mg, 2.0 mmol) and 
N-hydroxysuccinimide (255 mg, 2.2 mmol) in anhydrous DCM (10 ml) N,N’-
dicyclohexylcarbodiimide (454 mg, 2.2 mmol) was added at room temperature 
under argon. After 45 min, the precipitated urea was removed by filtration and 
the solvent removed in vacuo. The residual orange solid was purified by silica gel column chromatography 
eluting with anhydrous DCM to yield the pure product as a moisture-sensitive orange solid (612 mg, 95%). 1H 
NMR (300 MHz, CDCl3, 20°C, TMS) d = 2.95 (4H, s, 2x CH2), 7.53 (3H, m, PhH), 7.67 (1H, t 3J (H,H) = 7.8 
Hz, ArH m to N2), 7.97 (2H, m, PhH o to N2), 8.24 (2H, dd J = 1.5, 6.0 Hz, ArH o, p to C(O), N2), 8.69 (1H, s, 
ArH o to C(O), N2); 13C NMR (76 Mz, CDCl3, 20°C, TMS) d = 26.1, 123.5, 123.6, 125.3, 130.0, 130.2, 130.4, 
132.6, 133.0, 152.7, 153.0, 161.4, 169.6; MS (ES+) m/z = 324 (M+H), 346 (M+Na) 
 
5’-O-(4,4’-dimethoxytrityl)-2’-(N-(m-phenylazo)benzamido)-2’-deoxyuridine.  
To a stirred solution of m-phenylazobenzoic acid-N-
hydroxysuccinimidyl ester (260 mg, 0.80 mmol) in anhydrous DMF (5 
ml) at room temperature was added n-butylamine (10 µl, 0.10 mmol) 
and the reaction mixture maintained under these conditions for a 
further 10 min. The reaction mixture was transferred under argon to a 
flask containing 5’-O-(4,4’-dimethoxytrityl)-2’-amino-2’-deoxyuridine 
(250 mg, 0.46 mmol) and N,N-diisopropylethylamine (DIPEA: 80 µl, 0.47 mmol) added. The reaction was stirred 
under ambient conditions for a further 6 hours, a further aliquot of DIPEA (100 µl, 0.59 mmol) was added and 
the reaction stored at 3°C overnight. Excess activated ester was quenched by addition of n-butylamine (190 µl, 
1.92 mmol) and stirring at room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate (250 
ml) and washed successively with aqueous saturated NaHCO3 (2 x 150 ml) and saturated NaCl (2 x 150 ml). The 
organics were dried over anhydrous sodium sulfate, filtered and solvent removed in vacuo. The resultant red gum 
was purified by silica gel column chromatography, eluting with a gradient of 0 - 2% (v/v) methanol in DCM 
containing 1% (v/v) triethylamine to give the title compound as an orange solid (250 mg, 72 %). 1H NMR (300 
MHz, CDCl3, 20°C, TMS) d = 3.40 (2H, m, H5’, H5’’), 3.77 (6H, s, 2xOCH3), 4.22 (1H, s, H4’), 4.62 (1H, d 3J 
(H,H) = 4.8 Hz, H2’), 4.89 (1H, m, H3’), 5.43 (1H, d 3J (H,H) = 8.1Hz, H5), 6.28 (1H, d 3J (H,H) = 8.4 Hz, 
H1’), 6.84 (4H, d 3J (H,H) = 9.0 Hz, DMTr-H o- to OMe), 7.20 – 7.33 (¶7H, m, DMTr-H, NHC(O)AB), 7.40 - 
7.46 (6H, m, DMTr-H, AB-H), 7.58 (1H, d 3J (H,H) = 7.5 Hz, AB-H), 7.67 (1H, 3J (H,H) = 8.1 Hz, H6), 7.80 - 
7.94 (4H, m, AB-H), 8.30 (1H, s, AB-H); 13C NMR (101 MHz, CDCl3, 20°C, TMS) d = 55.7, 58.0, 64.1, 72.2, 
86.1, 86.9, 87.6, 103.6, 113.8; 122.3; 123.4; 127.6; 128.5; 128.6; 129.5; 129.8; 129.9; 130.6; 131.8; 134.7; 
135.5; 135.7; 140.5; 144.5; 151.9; 152.8; 152.9; 159.1; 163.5; 167.9; HRMS (ESI) 753.2791 (calc.753.2799 for 
MH+)  
 
 5’-O-(4,4’-dimethoxytrityl)-2'-(N-(m-phenylazo)benzamido)-2’-deoxyuridine-3’-O-(2-cyanoethyl-N,N-
diisopropylamino)-phosphoramidite.  
To a stirred solution of 5’-O-(4,4’-dimethoxytrityl)-2’-(N-(m-
phenylazo)benzamido)-2’-deoxyuridine (134 mg, 0.18 mmol) and 
DIPEA (67 µl, 0.73 mmol) in anhydrous DCM (3 ml) and THF (0.5 
ml) at room temperature was added 2-cyanoethyl-N,N-
diisopropylaminochlorophosphoramidite (57 µl, 0.36 mmol) dropwise 
over 3 min. The reaction was maintained under these conditions for a 
further 30 min and then quenched following addition of anhydrous methanol (90 µl, 2.22 mmol) and DIPEA (90 
µl 0.98 mmol) and stirring for a further 10 min. The reaction mixture was diluted with acid-free ethyl acetate (50 
ml) and washed successively with aqueous saturated NaHCO3 (2 x 50 ml), saturated NaCl (1 x 50 ml). The 
organics were dried over anhydrous sodium sulfate, filtered and solvent removed in vacuo. The resultant solid 
was purified by silica gel column chromatography, eluting with 2% (v/v) solutions of triethylamine in 3:1 
DCM:40-60 petroleum ether; pure DCM and 3:1 DCM : ethyl acetate. The title compound was isolated as an 
orange foam (160 mg, 0.17 mmol, 93 %). 1H NMR (300 MHz, CDCl3, 20°C, TMS) d = 1.00 – 1.35 (¶12H, m 2 x 
(CH3)2), 2.31 and 2.44 (2H, 2xm, CH2CN) 3.44 (2H, m, H5’, H5’’) 3.45 - 3.80 (4H, m, (-CH)2N, CH2O), 3.80 
(6H, s, 2xCH3O), 4.30 and 4.45 (1H, 2xs, H4’), 4.56 and 4.75 (1H, 2xdd, H2’), 4.97 and 5.13 (1H, 2xm, H3’), 
5.50 (1H, yt, H5), 6.26 (1H, yt, H1’), 6.87 (4H, 2xd 3J (H,H) = 8.9 Hz, DMTrH o- to OMe), 6.97 and 7.14 (1H, 
2xm, NHC(O)AB), 7.20 – 7.80 (¶14H, m, DMTrH, AB-H, H6), 7.90-8.15 (4H, m, AB-H), 8.32 (1H, s, AB-H); 
31P NMR (121 MHz, CDCl3, 20°C, 85% H3PO4) d = 149.4, 148.1 
 
p-Phenylazobenzoic acid-N-hydroxysuccinimidyl ester.  
To a stirred suspension of p-phenylazobenzoic acid (452 mg, 2.0 mmol) and 
N-hydroxysuccinimide (255 mg, 2.2 mmol) in anhydrous DCM (10 ml) N,N’-
dicyclohexylcarbodiimide (454 mg, 2.2 mmol) was added at room 
temperature under argon. After 45 min, the precipitated urea was removed by 
filtration and the solvent removed in vacuo. The residual orange solid was 
purified by silica gel column chromatography eluting with anhydrous DCM to yield the pure product as a 
moisture-sensitive orange solid (544 mg, 84%). 1H NMR (300 MHz, CDCl3, 20°C, TMS) d = 2.94 (4H, s, 2x 
CH2), 7.55 (3H, m, PhH), 7.97 (2H, m, PhH o to N2), 8.02 (2H, d 3J (H,H) = 8.4 Hz ArH o to C(O)), 8.30, (2H, d 
3J (H,H) = 8.4 Hz, ArH o to N2), 13C NMR (101 Mz, CDCl3, 20°C, TMS) d = 25.7, 123.0, 123.3, 126.5, 129.2, 
131.7, 132.1, 152.4, 156.1, 161.4, 169.2; CI+ MS m/z 324 (MH+)  
 
5’-O-(4,4’-dimethoxytrityl)-2’-(N-(p-phenylazo)benzamido)-2’-deoxyuridine.  
To a stirred solution of p-phenylazobenzoic acid-N-
hydroxysuccinimidyl ester (260 mg, 0.80 mmol) in anhydrous DMF (5 
ml) at room temperature was added n-butylamine (10 µl, 0.10 mmol) 
and the reaction mixture maintained under these conditions for a 
further 10 min. The reaction mixture was transferred under argon to a 
flask containing 5’-O-(4,4’-dimethoxytrityl)-2’-amino-2’-deoxyuridine (250 mg, 0.46 mmol) and N,N-
diisopropylethylamine (DIPEA: 80 µl, 0.47 mmol) added. The reaction was stirred under ambient conditions for a 
further 6 hours, a further aliquot of DIPEA (100 µl, 0.59 mmol) was added and the reaction stored at 3°C 
overnight. Excess activated ester was quenched by addition of n-butylamine (190 µl, 1.92 mmol) and stirring at 
room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate (250 ml) and washed 
successively with aqueous saturated NaHCO3 (2 x 150 ml) and saturated NaCl (2 x 150 ml). The organics were 
dried over anhydrous sodium sulfate, filtered and solvent removed in vacuo. The resultant red gum was purified 
by silica gel column chromatography, eluting with a gradient of 0 – 2% (v/v) methanol in DCM containing 1% 
(v/v) triethylamine to give the title compound as an orange solid (250 mg, 72 %). 1H NMR (300 MHz, CDCl3, 
20°C, TMS) d = 3.42 (2H, m, H5’, H5’’), 3.75 (6H, s, 2xOCH3), 4.23 (1H, s, H4’), 4.65 (1H, m, H2’), 4.77 (1H, 
m, H3’), 5.47 (1H, d 3J (H,H) = 8.2 Hz, H5), 6.20 (1H, d 3J (H,H) = 8.1 Hz, H1'), 6.89 (4H, d 3J (H,H) = 9.0 Hz, 
DMTr-H o- to OMe), 7.20 – 7.43 (¶10H, m, DMTr-H, NHC(O)AB). 7.48 (3H, m, AB-H) 7.67 (1 H, d, 3J (H,H)  
= 8.2 Hz, H6), 7.85-7.95 (6H, m, AB-H); 13C NMR (63 MHz, CDCl3, 20°C, TMS) d = 55.7, 57.9, 64.2, 72.1, 
86.3, 87.1, 87.6, 103.6, 113.8, 123.3, 123.6, 127.6, 128.5, 128.6, 128.7, 129.5, 130.6, 132.0, 135.4, 135.6, 
135.7, 140.5, 144.5, 152.0, 152.9, 154.8, 159.1, 163.7, 167.8; FAB+ MS m/z 754 (MH+) 
 
 5’-O-(4,4’-dimethoxytrityl)-2’-(N-(p-phenylazo)benzamido)-2’-deoxyuridine-3’-O-(2-cyanoethyl-N,N-
diisopropylamino)-phosphoramidite.  
To a stirred solution of 5’-O-(4,4’-dimethoxytrityl)-2’-(N-(p-
phenylazo)benzamido)-2’-deoxyuridine (250 mg, 0.33 mmol) and 
DIPEA (125 µl, 1.36 mmol) in anhydrous DCM (5 ml) and THF (2 
ml) at room temperature was added 2-cyanoethyl-N,N-
diisopropylaminochlorophosphoramidite (106 µl, 0.66 mmol) 
dropwise over 3 min. The reaction was maintained under these 
conditions for a further 30 min and then quenched following addition of anhydrous methanol (60 µl, 1.48 mmol) 
and DIPEA (60 µl 0.65 mmol) and stirring for a further 10 min. The reaction mixture was diluted with acid-free 
ethyl acetate (250 ml) and washed successively with aqueous saturated NaHCO3 (2 x 250 ml), saturated NaCl (1 
x 150 ml). The organics were dried over anhydrous sodium sulfate, filtered and solvent removed in vacuo. The 
resultant solid was purified by silica gel column chromatography, eluting with 2% (v/v) solutions of 
triethylamine in 3:1 DCM: 40-60 petroleum ether; pure DCM and 3:1 DCM : ethyl acetate. The title compound 
was isolated as an orange foam (308 mg, 0.32 mmol, 97 %). 1H NMR (300 MHz, CDCl3, 20°C, TMS) d = 0.95 – 
1.25 (¶12H, m 2 x (CH3)2), 2.33 and 2.48 (2H, 2xm, CH2CN) 3.36 (2H, m, H5’, H5’’) 3.40 - 3.80 (4H, m, (-
CH)2N, CH2O), 3.80 (6H, s, 2xCH3O), 4.30 and 4.46 (1H, 2xs, H4’), 4.53 and 4.69 (1H, 2xdd 3J (H,H) = 6.8 Hz, 
H2’), 4.97 and 5.09 (1H, 2xm, H3’), 5.49 (1H, yt, H5), 6.22 and 6.29 (1H, 2xd 3J (H,H) = 6.8 Hz, H1’), 6.82 
and 6.83 (4H, 2xd 3J (H,H) = 6.8 Hz, DMTrH o- to OMe), 6.97 and 7.14 (1H, 2xm, NHC(O)AB), 7.30 – 7.55 
(¶12H, m, DMTrH, AB-H), 7.72 and 7.81 (1H, 2xd 3J (H,H) = 8.2 Hz, H6), 7.85 – 7.90 (6H, m, AB-H); 31P 
NMR (101 MHz, CDCl3, 85% H3PO4) d = 152.1, 149.8; FAB+ MS m/z 853 (M-iPr2N), 883 (M-OCE), 954 
(M+H) 
 
 
Synthesis of oligonucleotides 
Oligosynthesis was carried out on Beckman Oligo 1000M and Expedite 8909 DNA/RNA synthesizers on a 1 
?mmol scale using standard DNA and RNA phosphoramidites from Link Technologies. Standard nucleobase 
protecting groups and 2’-O-TBDMS-protection were used. Benzylthiotetrazole (0.2 M) was used as activating 
agent. Oxidation was performed using 8:1:1 THF:pyridine:H2O containing either 50 mM or 20 mM I2 for, 
respectively, Beckman- or Expedite-run syntheses. Unmodified DNA and RNA were synthesized DMT-on and 
deprotected and purified according to standard procedures. The coupling time was extended (5-6 min) for 2’-
azobenzene-modified amidites. Deprotection of azobenzene-modified oligonucleotides was performed with 1.5 
ml of an anhydrous mixture of NH3/MeOH (dry MeOH saturated with gaseous ammonia at -10°C) overnight at 
room temperature. The decanted supernatant was evaporated and the crude oligonucleotides purified by RP-
HPLC (column: Hichrom KR100-5C18; buffer A: 0.1 M TEAAc, pH 6.5, 5% (v/v) MeCN; buffer B: 0.1 M 
TEAAc, pH 6.5, 65% (v/v) MeCN) monitoring absorbance in the range 200 – 400 (or 600) nm with a diode array 
detector. After evaporation of the buffer the oligonucleotides were desalted using standard SepPak protocols 
(Waters) and concentrations determined using UV absorbance at 260 nm. 
 
MALDI-TOF analysis of DNA-azobenzene conjugates 
 
DNA oligomer Mass (calc.) 
DRo 8438.79 (8440.46) 
DRm 8434.24 (8440.46) 
DRp 8434.17 (8440.46) 
ACC1oGGTA 2620.29 (2617.51) 
ACC1mGGTA 2619.58 (2617.51) 
ACC1pGGTA 2626.46 (2617.51) 
 
 
Photoswitching of DNA-azobenzene conjugates 
 
For the irradiation a Medium Pressure Hg Arc-lamp (100 W, Engelhard Hanovia of Canada Ltd.) was utilized. A 
band-pass filter was used for irradiation at 366 nm (4.13 W) and a cutoff filter was used for irradiation >400 nm 
(435 nm, 3.36 W) in combination with a water filter (1 cm) to prevent warming of the samples during prolonged 
irradiation. 
 
As the high concentrations of deoxyribozyme and labeled substrate used prevented full kinetic analysis, all 
constructs were assayed at a fixed set of standard conditions (20 mM substrate, 2 mM deoxyribozyme), and from 
the measured initial rates, apparent first order rate constants of the Z- and E-isomers were determined. 
 UV analysis of E ® Z photoswitching following irradiation at 366 nm and 435 nm 
 
ACC1oGGTA 
 
KEY 
 
¾ UV spectrum of 8-mer following 
HPLC purification 
¾ UV spectrum of 8-mer following 
irradiation at 366 nm for 8 min 
¾ UV spectrum of 8-mer following 
irradiation at 366 nm for 8 min 
and incubation at 26°C for 6 h
  
¾ UV spectrum of 8-mer following 
irradiation at 435 nm for 2 min 
  
 
 
 
ACC1mGGTA 
KEY 
 
¾ UV spectrum of 8-mer following 
HPLC purification 
¾ UV spectrum of 8-mer following 
irradiation at 366 nm for 8 min 
¾ UV spectrum of 8-mer following 
irradiation at 366 nm for 8 min 
and incubation at 26°C for 6 h 
¾ UV spectrum of 8-mer following 
irradiation at 435 nm for 2 min 
 
 
 
 
ACC1pGGTA 
 KEY 
 
¾ UV spectrum of 8-mer following 
HPLC purification 
¾ UV spectrum of 8-mer following 
irradiation at 366 nm for 5 min 
¾ UV spectrum of 8-mer following 
irradiation at 366 nm for a further  
3 min 
  
 
 
 
 
 
 
 
 HPLC analysis of E ® Z photoswitching efficiency following irradiation at 366 nm for 8 min 
 
Conditions for DRm and DRp: Hichrom KR100-5C18 with UV detection eluting with buffer A: 0.1 M TEAAc, 
pH 6.5, solvent C: MeCN, monitored at 260 nm; gradient indicated by purple line 
Conditions for ACC1oGGTA: Hichrom KR100-5C18 eluting with buffer A: 0.1 M TEAAc, pH 6.5, buffer B: 0.1 
M TEAAc, pH 6.5, 65% (v/v) MeCN, monitored at 260 nm; gradient indicated by turquoise line. 
 
DRm 
 
DRp 
 
ACC1oGGTA 
 
KEY 
 
14.69 min Z-DRm (75%) 
15.36 min E-DRm (25%) 
 
 
 
 
 
 
 
 
 
KEY 
 
14.64 min Z-DRp (61%) 
15.60 min E-DRp (39%) 
 
 
 
 
 
 
 
 
 
 
 
KEY 
 
15.44 min Z-ACC1oGGTA (86%) 
19.87 min E-ACC1oGGTA (14%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reversible photocontrol of deoxyribozyme-catalyzed RNA cleavage under multiple 
turnover conditions 
 
Activity assays for 10-23 deoxyribozymes in the PAGE format 
 
For the measurements of RNA-cleavage activities under multiple turnover conditions the deoxyribozyme 
construct (final concentration 2 mM or 1mM) was added to a buffered solution containing 50 mM Tris, pH 7.5, 40 
mM NaCl and 25 mM MgCl2 (all final concentrations). Preirradiation of these mixtures was performed at 366 
nm for 10 min and at 435 nm for 2 min in clear eppendorf tubes. The reaction was initiated by addition of the 
deoxyribozyme solutions to the substrate RNA (20 mM), yielding a total volume of 50 or 100 ml. Incubation was 
performed in the absence of light at 26°C, except for irrDRp, which was incubated under continuous irradiation 
at 366 nm (temperature under these conditions was determined to be 26°C). After appropriate time intervals 
aliquots (10 ml) were withdrawn, mixed with a stop solution (6 M urea, 50 mM EDTA) and frozen at -20°C. The 
samples were loaded on a 15% (w/v) (3% cross-linked) denaturing polyacrylamide sequencing gel and run at 900 
V for 2 hr. The gel was then removed from the plates and transferred onto a gel documentation system 
(Versadoc, Biorad) and analyzed. Quantitation of the bands was performed with the accompanying software 
(QuantityOne) such that the intensity of the product bands was set in relation to the sum of the intensities of the 
product and substrate bands which resulted in relative cleavage values.   
 
Activity assays for 10-23 deoxyribozymes using RP-HPLC analysis 
 
For the measurements of RNA-cleavage activities under multiple turnover conditions the deoxyribozyme 
construct (final concentration 2 mM) was added to a buffered solution containing 50 mM Tris, pH 7.5, 40 mM 
NaCl and 25 mM MgCl2 (all final concentrations). Preirradiation of these mixtures was performed at 366 nm for 
10 min and at 435 nm for 2 min in clear eppendorf tubes. The reaction was initiated by addition of the 
deoxyribozyme solutions to the substrate RNA (20 mM), yielding a total volume of 50 ml. Incubation was 
performed in the absence of light at 26°C, except for irrDRp, which was incubated under continuous irradiation 
at 366 nm (temperature under these conditions was determined to be 26°C). After 1.5 hr an aliquot (45 ml) was 
removed and quenched with 10 ml 250 mM EDTA. For the injection 40 ml 0.1 M TEAAc were added and the 
samples analyzed on RP-HPLC (column: Hichrom KR100-5C18, buffer A: 0.1 M TEAAc, pH 6.5; buffer B: 0.1 
M TEAAc, pH 6.5, 65% (v/v) MeCN; UV detection at 260 nm; gradient indicated by turquoise line). 
Quantitation was performed by determining peak areas for the two product peaks and set in relation to the sum of 
the peak areas of the product and substrate peaks which resulted in relative cleavage values. 
 
 
 
 
Reversible photocontrol of deoxyribozyme-catalyzed RNA cleavage under multiple 
turnover conditions 
 
HPLC activity assays 
 
DRwt  
 
 
d-aDRo 
 
 
d-aDRm 
 
 
d-aDRp 
 
Cleavage of unlabeled RNA substrate after 90 min 
by d-aDRs and irrDRs monitored by HPLC. 
 
 
 
 
 
 
 
 
 
 
 
 
irrDRo 
 
 
irrDRm 
 
 
irrDRp 
5'UGACAC 
5'AGAGAGA>p 
5'AGAGAGAUGACAC 
